{"id":"tp-54089","type":"article-newspaper","title":"Xilio Therapeutics Posts $9.98 Million in Q3 2026 Revenue","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54089","datePublished":"2026-11-11T14:35:49.000Z","dateModified":"2026-11-11T14:35:49.000Z","language":"en","abstract":"Collaboration and license revenue was $10.0 million, compared with $19.1 million a year earlier. Net loss per share was $0.30 on both basic and diluted bases.","section":"Business","references":[]}